Concepts (185)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Heart Transplantation | 21 | 2024 | 854 | 3.380 |
Why?
|
| Heart Failure | 19 | 2025 | 2131 | 1.960 |
Why?
|
| Heart-Assist Devices | 13 | 2025 | 1026 | 1.660 |
Why?
|
| Magnetic Resonance Imaging, Cine | 3 | 2024 | 147 | 0.910 |
Why?
|
| Pulmonary Heart Disease | 1 | 2022 | 4 | 0.800 |
Why?
|
| Cardiomyopathy, Hypertrophic | 3 | 2024 | 152 | 0.760 |
Why?
|
| Pharmaceutical Preparations | 1 | 2022 | 80 | 0.740 |
Why?
|
| Child | 42 | 2025 | 24244 | 0.690 |
Why?
|
| Spike Glycoprotein, Coronavirus | 1 | 2021 | 184 | 0.670 |
Why?
|
| Organ Transplantation | 1 | 2022 | 163 | 0.670 |
Why?
|
| Heart Defects, Congenital | 5 | 2025 | 1806 | 0.660 |
Why?
|
| Fecal Microbiota Transplantation | 1 | 2019 | 92 | 0.640 |
Why?
|
| Tracheostomy | 1 | 2020 | 191 | 0.610 |
Why?
|
| Infant, Newborn, Diseases | 1 | 2020 | 171 | 0.590 |
Why?
|
| Immunocompromised Host | 1 | 2019 | 300 | 0.570 |
Why?
|
| Hypertension, Pulmonary | 1 | 2022 | 431 | 0.560 |
Why?
|
| Retrospective Studies | 31 | 2025 | 16022 | 0.560 |
Why?
|
| Enterocolitis, Necrotizing | 1 | 2020 | 237 | 0.550 |
Why?
|
| Clostridium Infections | 1 | 2019 | 238 | 0.520 |
Why?
|
| Gadolinium DTPA | 1 | 2016 | 48 | 0.520 |
Why?
|
| Antibodies, Viral | 1 | 2021 | 1135 | 0.500 |
Why?
|
| Hypertrophy, Left Ventricular | 1 | 2016 | 107 | 0.500 |
Why?
|
| Stroke Volume | 2 | 2023 | 449 | 0.490 |
Why?
|
| Cardiomyopathies | 4 | 2022 | 481 | 0.460 |
Why?
|
| Tachycardia, Ventricular | 1 | 2016 | 196 | 0.440 |
Why?
|
| Postoperative Complications | 4 | 2022 | 3013 | 0.410 |
Why?
|
| Humans | 50 | 2025 | 123184 | 0.380 |
Why?
|
| Graft Rejection | 6 | 2024 | 582 | 0.380 |
Why?
|
| Adolescent | 18 | 2025 | 19118 | 0.340 |
Why?
|
| Child, Preschool | 15 | 2025 | 13889 | 0.330 |
Why?
|
| Anemia, Iron-Deficiency | 2 | 2021 | 133 | 0.300 |
Why?
|
| Female | 23 | 2025 | 65494 | 0.280 |
Why?
|
| Hospital Mortality | 3 | 2024 | 1010 | 0.280 |
Why?
|
| Male | 22 | 2025 | 60083 | 0.270 |
Why?
|
| Infant | 11 | 2025 | 12347 | 0.260 |
Why?
|
| Shock, Cardiogenic | 2 | 2024 | 187 | 0.240 |
Why?
|
| Registries | 3 | 2025 | 1393 | 0.220 |
Why?
|
| Tetralogy of Fallot | 3 | 2015 | 161 | 0.210 |
Why?
|
| Allografts | 1 | 2024 | 190 | 0.210 |
Why?
|
| Myocarditis | 1 | 2024 | 119 | 0.210 |
Why?
|
| Young Adult | 8 | 2024 | 8885 | 0.210 |
Why?
|
| Treatment Outcome | 10 | 2025 | 12129 | 0.210 |
Why?
|
| Isolated Noncompaction of the Ventricular Myocardium | 1 | 2023 | 43 | 0.210 |
Why?
|
| Hemorrhage | 2 | 2023 | 459 | 0.210 |
Why?
|
| Transplants | 1 | 2022 | 36 | 0.200 |
Why?
|
| Cohort Studies | 5 | 2024 | 4707 | 0.200 |
Why?
|
| Death, Sudden, Cardiac | 1 | 2024 | 247 | 0.200 |
Why?
|
| Warfarin | 1 | 2023 | 119 | 0.200 |
Why?
|
| Water-Electrolyte Imbalance | 1 | 2022 | 77 | 0.190 |
Why?
|
| Hemolysis | 1 | 2021 | 105 | 0.190 |
Why?
|
| Immunosuppressive Agents | 2 | 2023 | 644 | 0.190 |
Why?
|
| Heart Failure, Systolic | 1 | 2021 | 32 | 0.190 |
Why?
|
| Prognosis | 6 | 2024 | 4508 | 0.190 |
Why?
|
| Antibody Formation | 1 | 2021 | 256 | 0.180 |
Why?
|
| Heart Rate | 1 | 2023 | 587 | 0.180 |
Why?
|
| Mineralocorticoid Receptor Antagonists | 1 | 2020 | 27 | 0.180 |
Why?
|
| Patient Selection | 1 | 2024 | 686 | 0.180 |
Why?
|
| Infant, Newborn | 4 | 2022 | 8106 | 0.180 |
Why?
|
| Heart Valve Diseases | 1 | 2021 | 167 | 0.170 |
Why?
|
| Cardiomyopathy, Dilated | 1 | 2022 | 214 | 0.170 |
Why?
|
| Macrophages | 1 | 2024 | 603 | 0.170 |
Why?
|
| Cytomegalovirus | 1 | 2021 | 268 | 0.170 |
Why?
|
| Angiotensin Receptor Antagonists | 1 | 2020 | 121 | 0.170 |
Why?
|
| Down Syndrome | 1 | 2022 | 195 | 0.170 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2020 | 210 | 0.160 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2020 | 234 | 0.160 |
Why?
|
| Overweight | 1 | 2021 | 358 | 0.160 |
Why?
|
| Risk Factors | 6 | 2024 | 10021 | 0.160 |
Why?
|
| Transposition of Great Vessels | 1 | 2020 | 132 | 0.160 |
Why?
|
| Heart Ventricles | 2 | 2013 | 763 | 0.150 |
Why?
|
| Heart Diseases | 1 | 2023 | 486 | 0.150 |
Why?
|
| Capillaries | 1 | 2018 | 66 | 0.150 |
Why?
|
| Infant, Premature, Diseases | 1 | 2020 | 238 | 0.150 |
Why?
|
| Chronic Disease | 1 | 2022 | 1167 | 0.140 |
Why?
|
| Lung Transplantation | 1 | 2021 | 316 | 0.140 |
Why?
|
| Length of Stay | 2 | 2020 | 1285 | 0.140 |
Why?
|
| Thrombosis | 1 | 2022 | 521 | 0.140 |
Why?
|
| Heart Septal Defects, Ventricular | 1 | 2018 | 133 | 0.140 |
Why?
|
| Heart | 2 | 2022 | 725 | 0.140 |
Why?
|
| Intensive Care Units, Neonatal | 1 | 2020 | 312 | 0.140 |
Why?
|
| Clinical Trials as Topic | 1 | 2021 | 1089 | 0.140 |
Why?
|
| Hypoplastic Left Heart Syndrome | 1 | 2020 | 252 | 0.140 |
Why?
|
| Patient Readmission | 1 | 2020 | 366 | 0.130 |
Why?
|
| Graft Survival | 3 | 2024 | 525 | 0.130 |
Why?
|
| Electrocardiography, Ambulatory | 1 | 2016 | 60 | 0.130 |
Why?
|
| Stroke | 1 | 2023 | 958 | 0.130 |
Why?
|
| Recurrence | 1 | 2019 | 1422 | 0.130 |
Why?
|
| Follow-Up Studies | 4 | 2025 | 5050 | 0.130 |
Why?
|
| Age Factors | 1 | 2021 | 2801 | 0.120 |
Why?
|
| Acute Kidney Injury | 1 | 2022 | 609 | 0.120 |
Why?
|
| Adult | 10 | 2024 | 29065 | 0.120 |
Why?
|
| Diastole | 1 | 2015 | 171 | 0.120 |
Why?
|
| Magnetic Resonance Imaging | 4 | 2024 | 3529 | 0.120 |
Why?
|
| Ventricular Dysfunction, Right | 1 | 2015 | 78 | 0.120 |
Why?
|
| Echocardiography, Doppler | 1 | 2015 | 172 | 0.120 |
Why?
|
| Coronary Vessel Anomalies | 1 | 2018 | 274 | 0.110 |
Why?
|
| Prevalence | 1 | 2020 | 2407 | 0.110 |
Why?
|
| Cardiac Volume | 1 | 2013 | 17 | 0.110 |
Why?
|
| End Stage Liver Disease | 1 | 2015 | 178 | 0.110 |
Why?
|
| Antineoplastic Agents | 1 | 2022 | 1672 | 0.100 |
Why?
|
| United States | 3 | 2024 | 10632 | 0.100 |
Why?
|
| Pulmonary Valve Stenosis | 1 | 2013 | 40 | 0.100 |
Why?
|
| Models, Statistical | 1 | 2015 | 474 | 0.100 |
Why?
|
| Liver Transplantation | 1 | 2021 | 1014 | 0.100 |
Why?
|
| Contrast Media | 1 | 2016 | 469 | 0.100 |
Why?
|
| Ventricular Function, Right | 1 | 2013 | 112 | 0.100 |
Why?
|
| Survival Rate | 3 | 2025 | 1996 | 0.100 |
Why?
|
| Cardiovascular Physiological Phenomena | 1 | 2011 | 30 | 0.100 |
Why?
|
| Cardiac Catheterization | 3 | 2023 | 633 | 0.090 |
Why?
|
| Waiting Lists | 2 | 2024 | 225 | 0.090 |
Why?
|
| Transplant Recipients | 2 | 2023 | 209 | 0.090 |
Why?
|
| Hospitalization | 3 | 2024 | 1736 | 0.080 |
Why?
|
| Disease Progression | 1 | 2016 | 2024 | 0.080 |
Why?
|
| Ventricular Function, Left | 2 | 2023 | 500 | 0.080 |
Why?
|
| Myocardium | 2 | 2024 | 984 | 0.080 |
Why?
|
| Hemodynamics | 2 | 2022 | 848 | 0.080 |
Why?
|
| Anticoagulants | 2 | 2023 | 583 | 0.070 |
Why?
|
| Obesity | 2 | 2021 | 2227 | 0.070 |
Why?
|
| Abnormalities, Multiple | 1 | 2013 | 964 | 0.070 |
Why?
|
| Heart-Lung Transplantation | 1 | 2024 | 23 | 0.060 |
Why?
|
| North America | 1 | 2025 | 237 | 0.060 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2013 | 1100 | 0.060 |
Why?
|
| Predictive Value of Tests | 2 | 2023 | 2114 | 0.060 |
Why?
|
| Gadolinium | 1 | 2024 | 103 | 0.060 |
Why?
|
| Europe | 1 | 2024 | 375 | 0.050 |
Why?
|
| Time Factors | 2 | 2025 | 6211 | 0.050 |
Why?
|
| Autonomic Nervous System | 1 | 2023 | 45 | 0.050 |
Why?
|
| Cicatrix | 1 | 2024 | 125 | 0.050 |
Why?
|
| International Normalized Ratio | 1 | 2023 | 42 | 0.050 |
Why?
|
| Systemic Inflammatory Response Syndrome | 1 | 2024 | 171 | 0.050 |
Why?
|
| Sodium Potassium Chloride Symporter Inhibitors | 1 | 2022 | 31 | 0.050 |
Why?
|
| Chlorides | 1 | 2022 | 104 | 0.050 |
Why?
|
| Hirudins | 1 | 2022 | 37 | 0.050 |
Why?
|
| Catheters | 1 | 2022 | 89 | 0.050 |
Why?
|
| Sarcomeres | 1 | 2022 | 30 | 0.050 |
Why?
|
| Actin Cytoskeleton | 1 | 2022 | 44 | 0.050 |
Why?
|
| Antithrombins | 1 | 2022 | 56 | 0.050 |
Why?
|
| Body Mass Index | 2 | 2021 | 1541 | 0.050 |
Why?
|
| Transferrin | 1 | 2021 | 51 | 0.050 |
Why?
|
| Killer Cells, Natural | 1 | 2024 | 319 | 0.050 |
Why?
|
| Diuretics | 1 | 2022 | 158 | 0.050 |
Why?
|
| Ganciclovir | 1 | 2021 | 96 | 0.050 |
Why?
|
| Thinness | 1 | 2021 | 68 | 0.050 |
Why?
|
| Antibodies | 1 | 2022 | 370 | 0.050 |
Why?
|
| Sodium | 1 | 2022 | 291 | 0.050 |
Why?
|
| Anti-Arrhythmia Agents | 1 | 2022 | 218 | 0.050 |
Why?
|
| Heparin | 1 | 2022 | 227 | 0.040 |
Why?
|
| Cytoskeletal Proteins | 1 | 2022 | 269 | 0.040 |
Why?
|
| Societies, Medical | 1 | 2024 | 679 | 0.040 |
Why?
|
| Acute Disease | 1 | 2023 | 1092 | 0.040 |
Why?
|
| Creatinine | 1 | 2022 | 380 | 0.040 |
Why?
|
| Echocardiography | 2 | 2018 | 1062 | 0.040 |
Why?
|
| Cardiovascular Agents | 1 | 2020 | 86 | 0.040 |
Why?
|
| Case-Control Studies | 2 | 2019 | 3251 | 0.040 |
Why?
|
| Benchmarking | 1 | 2020 | 132 | 0.040 |
Why?
|
| Biopsy | 1 | 2023 | 1239 | 0.040 |
Why?
|
| Miniaturization | 1 | 2019 | 27 | 0.040 |
Why?
|
| Iron | 1 | 2021 | 261 | 0.040 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2022 | 459 | 0.040 |
Why?
|
| Muscle Proteins | 1 | 2022 | 416 | 0.040 |
Why?
|
| Recombinant Proteins | 1 | 2022 | 1385 | 0.040 |
Why?
|
| Aortic Valve | 1 | 2021 | 432 | 0.040 |
Why?
|
| Tissue Donors | 1 | 2021 | 496 | 0.040 |
Why?
|
| Peptide Fragments | 1 | 2022 | 748 | 0.040 |
Why?
|
| Sternotomy | 1 | 2018 | 42 | 0.040 |
Why?
|
| Practice Guidelines as Topic | 1 | 2024 | 1262 | 0.040 |
Why?
|
| Computed Tomography Angiography | 1 | 2018 | 195 | 0.030 |
Why?
|
| Patient Discharge | 1 | 2020 | 490 | 0.030 |
Why?
|
| Antiviral Agents | 1 | 2021 | 744 | 0.030 |
Why?
|
| Prosthesis Design | 1 | 2019 | 671 | 0.030 |
Why?
|
| Hospitals, Low-Volume | 1 | 2015 | 30 | 0.030 |
Why?
|
| Hospitals, High-Volume | 1 | 2015 | 35 | 0.030 |
Why?
|
| Risk Assessment | 1 | 2024 | 3334 | 0.030 |
Why?
|
| Biomarkers | 1 | 2024 | 2942 | 0.030 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2020 | 711 | 0.030 |
Why?
|
| Aorta | 1 | 2018 | 541 | 0.030 |
Why?
|
| Pulmonary Circulation | 1 | 2013 | 121 | 0.020 |
Why?
|
| Quality of Life | 1 | 2020 | 1932 | 0.020 |
Why?
|
| Exercise Test | 1 | 2011 | 250 | 0.020 |
Why?
|
| Ultrasonography | 1 | 2013 | 941 | 0.020 |
Why?
|
| Multivariate Analysis | 1 | 2011 | 1416 | 0.020 |
Why?
|
| Mice | 1 | 2022 | 17486 | 0.020 |
Why?
|
| Algorithms | 1 | 2011 | 1593 | 0.010 |
Why?
|
| Middle Aged | 1 | 2023 | 26002 | 0.010 |
Why?
|
| Animals | 1 | 2022 | 33714 | 0.010 |
Why?
|